About CorneaGen
CorneaGen is a company based in Seattle (United States) founded in 2017.. CorneaGen has raised $42 million across 3 funding rounds from investors including Petrichor and Flying L Partners. The company has 205 employees as of December 31, 2020. CorneaGen has completed 1 acquisition, including KeraLink International. CorneaGen offers products and services including CTAK, EndoSerter-PL, VisionGraft, and Geuder Pre-Loaded Glass Cannula. CorneaGen operates in a competitive market with competitors including Cellusion, EyeGate, CorNeat Vision, Avedro and EyeYon, among others.
- Headquarter Seattle, United States
- Employees 205 as on 31 Dec, 2020
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$42 M (USD)
in 3 rounds
-
Latest Funding Round
$25 M (USD), Debt – Conventional
Oct 07, 2019
-
Investors
Petrichor
& 1 more
-
Employee Count
205
as on Dec 31, 2020
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of CorneaGen
CorneaGen offers a comprehensive portfolio of products and services, including CTAK, EndoSerter-PL, VisionGraft, and Geuder Pre-Loaded Glass Cannula. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Provides laser-cut tissue inlays for enhanced vision in keratoplasty.
Pre-loaded tool for DSEK procedures to improve surgical outcomes.
Offers ready corneal grafts for ocular surgeries to restore sight.
Facilitates DMEK surgery with pre-loaded delivery for precision.
Unlock access to complete
Unlock access to complete
Funding Insights of CorneaGen
CorneaGen has successfully raised a total of $42M across 3 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $25 million completed in October 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Debt – Conventional — $25.0M
-
First Round
First Round
(05 Apr 2018)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2019 | Amount | Debt – Conventional - CorneaGen | Valuation |
investors |
|
| Feb, 2019 | Amount | Series B - CorneaGen | Valuation | Flying L Partners | |
| Apr, 2018 | Amount | Series A - CorneaGen | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in CorneaGen
CorneaGen has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Petrichor and Flying L Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Petrichor is engaged in supporting healthcare innovation through investments.
|
Founded Year | Domain | Location | |
|
Flying L Partners is focused on ophthalmic sector investments.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by CorneaGen
CorneaGen has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include KeraLink International. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Foundation focused on developing affordable corneal blindness treatment
|
1962 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - CorneaGen
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Corneagen Comparisons
Competitors of CorneaGen
CorneaGen operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cellusion, EyeGate, CorNeat Vision, Avedro and EyeYon, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
iPS cell-based technology for corneal endothelium regeneration is developed.
|
|
| domain | founded_year | HQ Location |
Therapeutics and drug delivery systems for eye diseases are developed.
|
|
| domain | founded_year | HQ Location |
Nanotechnology-based artificial corneal implants are developed for ophthalmic use.
|
|
| domain | founded_year | HQ Location |
Corneal collagen cross-linking technology is developed for ophthalmic applications.
|
|
| domain | founded_year | HQ Location |
Ophthalmic devices for corneal edema treatment are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Corneagen
Frequently Asked Questions about CorneaGen
When was CorneaGen founded?
CorneaGen was founded in 2017 and raised its 1st funding round 1 year after it was founded.
Where is CorneaGen located?
CorneaGen is headquartered in Seattle, United States. It is registered at Seattle, Washington, United States.
Who is the current CEO of CorneaGen?
Monty Montoya is the current CEO of CorneaGen.
Is CorneaGen a funded company?
CorneaGen is a funded company, having raised a total of $42M across 3 funding rounds to date. The company's 1st funding round was a Series A of $5M, raised on Apr 05, 2018.
How many employees does CorneaGen have?
As of Dec 31, 2020, the latest employee count at CorneaGen is 205.
What does CorneaGen do?
CorneaGen was founded in 2017 and is based in Seattle, United States. Operations center on the development of therapeutic devices within the ophthalmology sector, specifically for corneal transplant procedures. Key products include Ampho B, Pre-Loaded Cannula, Cannula, Donor Punch, EndoSerter, and Recipient Trephine. These devices support surgical processes for corneal care and are targeted at medical professionals in the field.
Who are the top competitors of CorneaGen?
What products or services does CorneaGen offer?
CorneaGen offers CTAK, EndoSerter-PL, VisionGraft, and Geuder Pre-Loaded Glass Cannula.
How many acquisitions has CorneaGen made?
CorneaGen has made 1 acquisition, including KeraLink International.
Who are CorneaGen's investors?
CorneaGen has 2 investors. Key investors include Petrichor, and Flying L Partners.